Pricing Log in Create free account

Neuronetics, Inc. (STIM) vs TriSalus Life Sciences, Inc. (TLSI)

Neuronetics, Inc. and TriSalus Life Sciences, Inc. are both Medical Devices companies. TriSalus Life Sciences, Inc. is the larger, with a market value of $217.4M against $185.2M — 1.2× the size. TriSalus Life Sciences, Inc. grew revenue faster over the last twelve months: 25.3% against 23.0%. Neuronetics, Inc. has the higher net margin (−14.5% vs −130.2%) and the lower return on invested capital (−16.7% vs 0.00%). Across the 17 metrics below, Neuronetics, Inc. leads on 12 and TriSalus Life Sciences, Inc. on 5.

Valuation

Metric STIM TLSI Medical Devices median
P/E n/m n/m 25.58
P/S 1.18 4.60 2.54
P/B 8.39 31.69 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 1.47 4.32 2.72
Earnings yield (13.52%) (36.52%) (12.82%)
Free cash flow yield (4.90%) (11.55%) (8.18%)

Profitability

Metric STIM TLSI Medical Devices median
Gross margin 50.68% 85.79% 57.76%
Operating margin (9.39%) (67.68%) (15.07%)
Net margin (14.45%) (130.17%) (14.45%)
Free cash flow margin (5.18%) (51.56%) (3.88%)
Return on equity (85.85%) 911.60% (10.35%)
Return on assets (16.64%) (113.09%) (17.26%)
Return on invested capital (16.72%) 0.00% (5.27%)

Growth

Metric STIM TLSI Medical Devices median
Revenue growth (TTM) 23.01% 25.25% 10.41%
EPS growth (last fiscal year) 56.93% (40.46%) 28.17%
Revenue growth, 5-year CAGR 24.81% — 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric STIM TLSI Medical Devices median
Debt to equity 2.76 5.05 0.04
Current ratio 2.01 5.35 2.74
Net debt to EBITDA (1.12) (0.50) 0.54

Dividend

Metric STIM TLSI Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric STIM TLSI Medical Devices median
Market cap 185.16m 217.36m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack